COMPANY

Accelevir Diagnostics LLC

HQ: Baltimore, MD source · accelevirdx.com ↗ · Mid-Atlantic

Service / Tools company

Keywords: flow cytometry NGS qPCR

Type: CRO
Services: Bioanalytical, Biorepository / biospecimens, Characterization / analytical, Regulatory, Sequencing / genomics, Viral vector

Tags: Bioanalytical, Biorepository / biospecimens, CRO, Characterization / analytical, Regulatory, Sequencing / genomics, Viral vector

Request a quote Opens the company's own website

Location: Baltimore, MD · source · Oct 14, 2026

Profile checked Oct 10, 2026

20NIH grants

NIH awards 20

Annual award amounts. Total $13.6M.

Sep 17, 2026 NIH award 3R24AI143502-07S1 FY2026: $531,874 awarded for that fiscal year; activity R24 (OTHER_NIH); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. Centralized Resource to source ↗
May 14, 2026 NIH award 5R24AI143502-07 FY2026: $764,899 awarded for that fiscal year; activity R24 (OTHER_NIH); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. Centralized Resource to A source ↗
Apr 9, 2025 NIH award 2R24AI143502-06 FY2025: $764,899 awarded for that fiscal year; activity R24 (OTHER_NIH); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. Centralized Resource to A source ↗
May 23, 2024 NIH award 5U24AI143502-05 FY2024: $749,588 awarded for that fiscal year; activity U24 (OTHER_NIH); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. Centralized Resource to A source ↗
Apr 7, 2023 NIH award 5U24AI143502-04 FY2023: $1,476,344 awarded for that fiscal year; activity U24 (OTHER_NIH); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. Centralized Resource to source ↗
2023 NIH contract (government contract; not a grant and not an investment round) 75N93023C00017-0-9999-1 FY2023: $2,000,000 awarded for that fiscal year; activity N44 (OTHER_NIH); PI LAIRD, GREGORY; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. P source ↗
Jul 19, 2022 NIH award 5R43AI165128-02 FY2022: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. IPDA for High-Priority HIV-1 S source ↗
Mar 23, 2022 NIH award 5U24AI143502-03 FY2022: $1,167,880 awarded for that fiscal year; activity U24 (OTHER_NIH); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. Centralized Resource to source ↗
Jul 23, 2021 NIH award 1R43AI165126-01 FY2021: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. HIV-1 EnvLRS: a scalable, sequ source ↗
Jul 6, 2021 NIH award 1R43AI165128-01 FY2021: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. IPDA for High-Priority HIV-1 S source ↗
Mar 26, 2021 NIH award 5U24AI143502-02 FY2021: $749,588 awarded for that fiscal year; activity U24 (OTHER_NIH); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. Centralized Resource to A source ↗
Apr 13, 2020 NIH award 1U24AI143502-01A1 FY2020: $749,993 awarded for that fiscal year; activity U24 (OTHER_NIH); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. Centralized Resource to source ↗
2020 NIH contract (government contract; not a grant and not an investment round) 75N93020C00015-0-9999-1 FY2020: $299,975 awarded for that fiscal year; activity N43 (OTHER_NIH); PI LAIRD, GREGORY; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. IPD source ↗
Dec 12, 2019 NIH award 1R43AI149816-01 FY2020: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. Development of Intact Proviral source ↗
Dec 31, 2018 NIH award 5R44AI124996-03 FY2019: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. A Novel Test to Measure Late source ↗
Aug 15, 2018 NIH award 1R43AI142866-01 FY2018: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. Development of a quantitative source ↗
Dec 22, 2017 NIH award 2R44AI124996-02 FY2018: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. A Novel Test to Measure Late source ↗
Aug 17, 2017 NIH award 1R43AI131900-01A1 FY2017: $288,740 awarded for that fiscal year; activity R43 (SBIR); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. Highly specific HIV-1 mRNA d source ↗
Jul 28, 2017 NIH award 1R43AI131826-01 FY2017: $297,200 awarded for that fiscal year; activity R43 (SBIR); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. Development of a next-generati source ↗
Jun 27, 2016 NIH award 1R43AI124996-01A1 FY2016: $259,322 awarded for that fiscal year; activity R43 (SBIR); PI LAIRD, GREGORY MICHAEL; recipient as written: ACCELEVIR DIAGNOSTICS, LLC, BALTIMORE, MD. A Novel Test to Measure Late source ↗

Funding and NIH signals

NIH award NIH awarded $532K (NIH grant 3R24AI143502-07S1, supplement, notice Sep 17, 2026); 2 NIH awards totaling $1.3M in the last 12 months. NIH RePORTER 3R24AI143502-07S1 (Sep 17, 2026)
Evidence (2 events)
- Sep 17, 2026 · NIH RePORTER 3R24AI143502-07S1
  Organization: ACCELEVIR DIAGNOSTICS, LLC; City/State: BALTIMORE, MD; Project number: 3R24AI143502-07S1; Activity code: R24; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 531874; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Centralized Resource to Accurately Quantify Latent and Expressed HIVReservoirs; Organization type: Domestic For-Profits
- May 14, 2026 · NIH RePORTER 5R24AI143502-07
  Organization: ACCELEVIR DIAGNOSTICS, LLC; City/State: BALTIMORE, MD; Project number: 5R24AI143502-07; Activity code: R24; Fiscal year: 2026; Award notice date: 2026-05-14; FY total cost (award amount): 764899; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Centralized Resource to Accurately Quantify Latent and Expressed HIVReservoirs; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals